Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1070 | 985 | 1224 | 1087 | 1365 | 1684 |
Fund Return | 6.96% | -1.52% | 22.41% | 2.81% | 6.43% | 5.35% |
Place in category | 420 | 464 | 340 | 143 | 229 | 116 |
% in Category | 59 | 68 | 52 | 23 | 37 | 33 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity 500 Index Institutional Pr | 631.62B | 20.96 | 9.07 | 12.99 | ||
Fidelity Contrafund | 142.53B | 30.86 | 9.80 | 15.03 | ||
Fidelity Contrafund K | 12.59B | 30.89 | 9.88 | 15.12 | ||
Fidelity Total Market Index Instl b | 107.41B | 19.75 | 7.53 | 12.38 | ||
Fidelity Blue Chip Growth | 66.2B | 28.77 | 6.99 | 17.42 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Total Intl Stock Index Inv | 204.36B | 8.15 | 1.40 | 4.88 | ||
Vanguard Total Intl Stock Index Adm | 75.61B | 8.18 | 1.45 | 4.94 | ||
Fidelity Series Global ex US Index | 49.29B | 8.52 | 1.64 | 4.77 | ||
Strategic Advisers International I | 44.53B | 8.45 | 1.91 | 6.07 | ||
Vanguard Total Intl Stock Index I | 41.42B | 8.23 | 1.49 | 4.97 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
MSCI EAFE Index Future Dec 24 | - | 2.30 | - | - | |
Novo Nordisk B | DK0062498333 | 2.13 | 782.3 | +0.84% | |
ASML Holding | NL0010273215 | 1.85 | 677.90 | +2.08% | |
Nestle | CH0038863350 | 1.47 | 76.60 | 0.00% | |
AstraZeneca | GB0009895292 | 1.35 | 10,790.0 | +2.24% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | BUY | Strong Sell | Strong Buy |
Summary | Buy | Neutral | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review